Sort   by:  
 Page size 
UnknownTolerability, Safety, Pharmacokinetics, and Immunogenicity of a Novel SARS-CoV-2 Neutralizing Antibody, Etesevimab, in Chinese Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, First-in-Human Phase 1 Study.
Not available
S-EPMC8284438 | biostudies-literature
UnknownCharacterization of the high-affinity anti-CTLA-4 monoclonal antibody JS007 for immune checkpoint therapy of cancer.
Not available
S-EPMC9754112 | biostudies-literature
UnknownAxitinib in Combination With Toripalimab, a Humanized Immunoglobulin G4 Monoclonal Antibody Against Programmed Cell Death-1, in Patients With Metastatic Mucosal Melanoma: An Open-Label Phase IB Trial.
Not available
S-EPMC6839911 | biostudies-literature
UnknownCase Report: Complete Remission With Anti-PD-1 and Anti-VEGF Combined Therapy of a Patient With Metastatic Primary Splenic Angiosarcoma.
Not available
S-EPMC8928100 | biostudies-literature
UnknownQuality comparability assessment of a SARS-CoV-2-neutralizing antibody across transient, mini-pool-derived and single-clone CHO cells.
Not available
S-EPMC8726686 | biostudies-literature
UnknownNeoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II study.
Not available
S-EPMC11260571 | biostudies-literature
UnknownEtesevimab in combination with JS026 neutralizing SARS-CoV-2 and its variants.
Not available
S-EPMC8843163 | biostudies-literature
UnknownShort-course radiotherapy combined with chemotherapy and PD-1 inhibitor in low-lying early rectal cancer: study protocol for a single-arm, multicentre, prospective, phase II trial (TORCH-E).
Not available
S-EPMC10565143 | biostudies-literature
UnknownA benchmarking framework for the accurate and cost-effective detection of clinically-relevant structural variants for cancer target identification and diagnosis.
Not available
S-EPMC10792779 | biostudies-literature
UnknownToripalimab plus axitinib in patients with metastatic mucosal melanoma: 3-year survival update and biomarker analysis.
Not available
S-EPMC9066368 | biostudies-literature
Sort   by:  
 Page size